The Drug Regulatory Authority of Pakistan (DRAP) has approved the ‘AlnnoVent AVB-100’, an intensive care unit (ICU) ventilator developed domestically. This milestone signifies Pakistan’s progress in medical device manufacturing, aiming to reduce reliance on imports and enhance healthcare self-sufficiency.
Advancements in Local Medical Device Production
The ‘AlnnoVent AVB-100’ is set for market release in 2025, representing a significant achievement in Pakistan’s medical technology sector. The global medical device industry is valued at approximately $600 billion, with Pakistan’s market share currently less than 1%. The introduction of locally produced devices like the ‘AlnnoVent AVB-100’ is expected to boost Pakistan’s presence in this sector.
Government Support and Future Prospects
Industry experts emphasize the need for government backing to expand local production capabilities. Supportive policies and investment in high-tech engineering services are crucial for sustaining growth and meeting international standards. The success of the ‘AlnnoVent AVB-100’ could pave the way for further innovations in Pakistan’s healthcare industry.
